Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Oncogene. 2023 Jun 24;42(30):2347–2359. doi: 10.1038/s41388-023-02756-w

Table 1. Patient information for patient-derived tumors treated with enzalutamide ex vivo:

Therapy-naïve PCa patient tissue information, including gleason score (GS), for patient-derived explants treated ex vivo and assessed by ROS assay.

Patient Number GS
1 7
2 9
3 7